ATE355364T1 - Klonierte glutaminsäure-decarboxylase - Google Patents

Klonierte glutaminsäure-decarboxylase

Info

Publication number
ATE355364T1
ATE355364T1 AT00102229T AT00102229T ATE355364T1 AT E355364 T1 ATE355364 T1 AT E355364T1 AT 00102229 T AT00102229 T AT 00102229T AT 00102229 T AT00102229 T AT 00102229T AT E355364 T1 ATE355364 T1 AT E355364T1
Authority
AT
Austria
Prior art keywords
cloned
acid decarboxylase
glutamine acid
gad65
polypeptides
Prior art date
Application number
AT00102229T
Other languages
English (en)
Inventor
Allan J Tobin
Mark G R W Erlander
Daniel L Kaufman
Michael J Clare-Salzler
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE355364T1 publication Critical patent/ATE355364T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y401/00Carbon-carbon lyases (4.1)
    • C12Y401/01Carboxy-lyases (4.1.1)
    • C12Y401/01015Glutamate decarboxylase (4.1.1.15)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
AT00102229T 1991-06-18 1992-06-17 Klonierte glutaminsäure-decarboxylase ATE355364T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71690991A 1991-06-18 1991-06-18

Publications (1)

Publication Number Publication Date
ATE355364T1 true ATE355364T1 (de) 2006-03-15

Family

ID=24879950

Family Applications (2)

Application Number Title Priority Date Filing Date
AT92110308T ATE207537T1 (de) 1991-06-18 1992-06-17 Klonierte glutaminsäure-decarboxylase
AT00102229T ATE355364T1 (de) 1991-06-18 1992-06-17 Klonierte glutaminsäure-decarboxylase

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT92110308T ATE207537T1 (de) 1991-06-18 1992-06-17 Klonierte glutaminsäure-decarboxylase

Country Status (9)

Country Link
EP (2) EP0519469B1 (de)
JP (1) JP4072922B2 (de)
KR (1) KR100262247B1 (de)
AT (2) ATE207537T1 (de)
AU (1) AU661684B2 (de)
CA (1) CA2070004C (de)
DE (2) DE69232147T2 (de)
DK (1) DK0519469T3 (de)
ES (2) ES2165350T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674978A (en) * 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
DK88093D0 (da) * 1993-07-28 1993-07-28 Novo Nordisk As Stabilt praeparat
CA2140591A1 (en) 1994-01-20 1995-07-21 Josef Endl Antigen-specific, activated t lymphocytes, detection and use
DE19525784A1 (de) * 1995-07-14 1997-01-16 Boehringer Mannheim Gmbh Autoreaktive Peptide aus der humanen Glutamin-Decarboxylase (GAD)
KR19990063648A (ko) * 1995-09-21 1999-07-26 프레드한 아룬디프 에스 글루타민산 데카복실라제에 대한 항체와 폴리(에틸렌 글리콜)공액물을 섬세포에 제공하는 방법
EP1274452A4 (de) * 2000-04-17 2004-11-10 Univ Loma Linda Methode zur prävention und behandlung von diabetes
GB0105360D0 (en) * 2001-03-03 2001-04-18 Glaxo Group Ltd Chimaeric immunogens
US20030054414A1 (en) * 2001-09-17 2003-03-20 George Jackowski Diagnosis and treatment of early pre-type-1 diabetes utilizing glial fibrillary acidic protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5205274A (en) * 1989-09-22 1993-04-27 Patentsmith Ii, Inc. Turntable convection oven
ATE144326T1 (de) * 1990-08-17 1996-11-15 Univ Florida Verfahren und komposition zum frühnachweiss und behandlung insulinabhängiger diabetes
WO1992004632A1 (en) * 1990-09-07 1992-03-19 The Regents Of The University Of California Methods for the diagnosis and treatment of diabetes
DK0572478T3 (da) * 1991-02-22 2006-01-16 Inst Medical W & E Hall HBGAD- og HIGAD-polypeptider og nukleinsyre og anvendelse heraf til diagnostik og behandling af GAD-autoantigen-associerede sygdomme

Also Published As

Publication number Publication date
ES2165350T3 (es) 2002-03-16
DE69232147T2 (de) 2002-06-20
AU661684B2 (en) 1995-08-03
KR930000684A (ko) 1993-01-15
CA2070004C (en) 2007-08-21
EP0519469B1 (de) 2001-10-24
EP1026238A2 (de) 2000-08-09
EP1026238B1 (de) 2007-02-28
JP4072922B2 (ja) 2008-04-09
EP0519469A1 (de) 1992-12-23
CA2070004A1 (en) 1992-12-19
AU1516392A (en) 1992-12-24
ES2281317T3 (es) 2007-10-01
ATE207537T1 (de) 2001-11-15
DE69233685D1 (de) 2007-04-12
DE69233685T2 (de) 2007-12-06
JPH0770182A (ja) 1995-03-14
KR100262247B1 (ko) 2000-07-15
EP1026238A3 (de) 2000-09-27
DK0519469T3 (da) 2001-12-10
DE69232147D1 (de) 2001-11-29

Similar Documents

Publication Publication Date Title
NO1994025I1 (no) Human immun (¿)-interferon og alleliske og redundante variasjoner derav
ATE221125T1 (de) Klonierte glutaminsäure-decarboxylase
HK1005594A1 (en) Interleukin-4 protein having bcgf and tcgf activity on human cells (human interleukin-4)
EP0251037A3 (en) Novel human tnf polypeptide mutants and dnas encoding said mutants
DK135488A (da) Il-3-protein, isaer humant il-3, dets fremstilling og anvendelse i farmaceutica, vektor, som koder proteinet, samt celler transformeret med vektoren
NO891716L (no) Ekspresjon av humant serumalbumin i metylotrofe gjaersorter
ATE355364T1 (de) Klonierte glutaminsäure-decarboxylase
ATE121754T1 (de) Vakzine gegen bordetella.
DE69229862D1 (de) Cysteinfreie il-6 mutanten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties